1. Home
  2. NXL vs MSAI Comparison

NXL vs MSAI Comparison

Compare NXL & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • MSAI
  • Stock Information
  • Founded
  • NXL 2010
  • MSAI 1995
  • Country
  • NXL United States
  • MSAI United States
  • Employees
  • NXL N/A
  • MSAI N/A
  • Industry
  • NXL Medical Specialities
  • MSAI
  • Sector
  • NXL Health Care
  • MSAI
  • Exchange
  • NXL Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • NXL 21.0M
  • MSAI 24.2M
  • IPO Year
  • NXL 2022
  • MSAI N/A
  • Fundamental
  • Price
  • NXL $0.95
  • MSAI $0.66
  • Analyst Decision
  • NXL Strong Buy
  • MSAI Strong Buy
  • Analyst Count
  • NXL 1
  • MSAI 1
  • Target Price
  • NXL $5.00
  • MSAI $2.50
  • AVG Volume (30 Days)
  • NXL 87.1K
  • MSAI 119.8K
  • Earning Date
  • NXL 08-07-2025
  • MSAI 08-13-2025
  • Dividend Yield
  • NXL N/A
  • MSAI N/A
  • EPS Growth
  • NXL N/A
  • MSAI N/A
  • EPS
  • NXL N/A
  • MSAI N/A
  • Revenue
  • NXL $131,065.00
  • MSAI $6,297,000.00
  • Revenue This Year
  • NXL $79.59
  • MSAI $66.87
  • Revenue Next Year
  • NXL $334.65
  • MSAI $81.01
  • P/E Ratio
  • NXL N/A
  • MSAI N/A
  • Revenue Growth
  • NXL N/A
  • MSAI N/A
  • 52 Week Low
  • NXL $0.59
  • MSAI $0.52
  • 52 Week High
  • NXL $4.49
  • MSAI $3.33
  • Technical
  • Relative Strength Index (RSI)
  • NXL 30.94
  • MSAI 47.40
  • Support Level
  • NXL $0.89
  • MSAI $0.52
  • Resistance Level
  • NXL $1.03
  • MSAI $0.68
  • Average True Range (ATR)
  • NXL 0.08
  • MSAI 0.06
  • MACD
  • NXL -0.00
  • MSAI 0.01
  • Stochastic Oscillator
  • NXL 18.75
  • MSAI 71.19

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc build and deploy intelligent multi-sensing platforms incorporating edge and cloud software solutions that leverage artificial intelligence (AI). It is a provider of sensing systems built around high-resolution thermal imagers, visible and acoustic imagers, as well as vibration and laser spectroscopy sensors, that perceive and measure heat, sound, vibration, and gas in industrial assets and the surrounding environment, helping companies gain insight to protect and manage their most important assets and infrastructure. It also offers a wide range of form factors for its sensor devices, including, among other form factors, small to large handheld designs with built-in displays and controls, and fixed-mounted single- and multi-sensor camera sensor systems.

Share on Social Networks: